Helus Pharma completes enrollment in phase 3 depression study

July 21, 2026 10:55 AM

Helus Pharma (Nasdaq: HELP, Cboe CA: HELP) announced it has completed enrollment in the APPROACH Phase 3 pivotal study of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found